| Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 N Van Doremalen, T Bushmaker, DH Morris, MG Holbrook, A Gamble, ... New England journal of medicine 382 (16), 1564-1567, 2020 | 12711 | 2020 |
| Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility MM Arons, KM Hatfield, SC Reddy, A Kimball, A James, JR Jacobs, ... New England journal of medicine 382 (22), 2081-2090, 2020 | 2465 | 2020 |
| Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020 A Kimball MMWR. Morbidity and mortality weekly report 69, 2020 | 1355 | 2020 |
| An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice TP Sheahan, AC Sims, S Zhou, RL Graham, AJ Pruijssers, ML Agostini, ... Science translational medicine 12 (541), eabb5883, 2020 | 1066 | 2020 |
| Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020 FP Havers, C Reed, T Lim, JM Montgomery, JD Klena, AJ Hall, AM Fry, ... JAMA internal medicine 180 (12), 1576-1586, 2020 | 800 | 2020 |
| Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States J Harcourt, A Tamin, X Lu, S Kamili, SK Sakthivel, J Murray, K Queen, ... Emerging infectious diseases 26 (6), 1266, 2020 | 630 | 2020 |
| Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy—SET-NET, 16 jurisdictions, March 29–October 14, 2020 KR Woodworth MMWR. Morbidity and Mortality Weekly Report 69, 2020 | 581* | 2020 |
| US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2 X Lu, L Wang, SK Sakthivel, B Whitaker, J Murray, S Kamili, B Lynch, ... Emerging infectious diseases 26 (8), 1654, 2020 | 559 | 2020 |
| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 459 | 2021 |
| The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled … NG Rouphael, M Paine, R Mosley, S Henry, DV McAllister, H Kalluri, ... The Lancet 390 (10095), 649-658, 2017 | 377 | 2017 |
| Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Nature medicine 26 (6), 861-868, 2020 | 337 | 2020 |
| Public Health–Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility MM Arons, KM Hatfield, SC Reddy, A Kimball, A James, JR Jacobs, ... N Engl J Med 382 (22), 2081-2090, 2020 | 335 | 2020 |
| 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales JH Kuhn, S Adkins, D Alioto, SV Alkhovsky, GK Amarasinghe, SJ Anthony, ... Archives of virology 165 (12), 3023-3072, 2020 | 321 | 2020 |
| Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 KL Bajema, RE Wiegand, K Cuffe, SV Patel, R Iachan, T Lim, A Lee, ... JAMA internal medicine 181 (4), 450-460, 2021 | 306 | 2021 |
| Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses—Wisconsin, September–October 2020 IW Pray MMWR. Morbidity and mortality weekly report 69, 2021 | 280 | 2021 |
| Evaluation of Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites—Pima County, Arizona, November 3–17, 2020 JL Prince-Guerra MMWR. Morbidity and mortality weekly report 70, 2021 | 250 | 2021 |
| SARS-CoV-2 infections and serologic responses from a sample of US Navy service members—USS Theodore Roosevelt, April 2020 DC Payne MMWR. Morbidity and mortality weekly report 69, 2020 | 243 | 2020 |
| Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network—13 academic medical centers, April–June 2020 WH Self MMWR. Morbidity and mortality weekly report 69, 2020 | 239 | 2020 |
| Activation of nuclear factor-κB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma NJ Thornburg, R Pathmanathan, N Raab-Traub Cancer research 63 (23), 8293-8301, 2003 | 221 | 2003 |
| Estimated US infection-and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021 JM Jones, M Stone, H Sulaeman, RV Fink, H Dave, ME Levy, ... Jama 326 (14), 1400-1409, 2021 | 187 | 2021 |
